A rare case report on uterine perforation by levonorgestrel releasing intrauterine device
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20230554Keywords:
LNG-IUD, Uterine perforation, Contraception, Intrauterine device, LevonorgestrelAbstract
A levonorgestrel-containing intrauterine contraceptive devices are widely used in contemporary gynaecology, primarily as an effective method for contraception and for control of menstrual disorders like menorrhagia and dysmenorrhea. A case report of the uterine perforation by the levonorgestrel-releasing intrauterine device (LNG-IUD) in a 33-year-old asymptomatic woman after an 18-month of insertion. On routine cervical smear examination, the LNG-IUD threads were not visualised through the cervical os. After abdominal ultrasound scan the confirmation of perforated LNG-IUD was done and was removed laparoscopically.
References
Trussell J, Guthrie K. Lessons from the contraceptive CHOICE project: the Hull long-acting reversible contraception (LARC) initiative. J Fam Plann Reprod Health Care. 2015;41(1):60-3.
Barnett C, Moehner S, Minh T, Heinemann K. Perforation risk and intra-uterine devices: results of the EURAS-IUD 5-year extension study. European J Contracept Reproduct Health Care. 2017;22(6):424-8.
World Health Organization (WHO); Johns Hopkins Center for Communication Programs (CCP), knowledge for health project. Family planning: a global handbook for providers. 3rd ed. Baltimore and Geneva: CCP and WHO; 2018.
Reinecke I, Hofmann B, Mesic E, Drenth HJ, Garmann D. An integrated population pharmacokinetic analysis to characterize levonorgestrel pharmacokinetics after different administration routes. J Clin Pharmacol. 2018;58(12):1639-54.
